HSPB8 antibody
- Known as:
- HSPB8 (anti-)
- Catalog number:
- orb41106
- Product Quantity:
- 100 ug
- Category:
- -
- Supplier:
- Biorb
- Gene target:
- HSPB8 antibody
Related genes to: HSPB8 antibody
- Gene:
- HSPB8 NIH gene
- Name:
- heat shock protein family B (small) member 8
- Previous symbol:
- -
- Synonyms:
- H11, E2IG1, HSP22, HspB8, CMT2L
- Chromosome:
- 12q24.23
- Locus Type:
- gene with protein product
- Date approved:
- 2004-01-29
- Date modifiied:
- 2019-04-23
Related products to: HSPB8 antibody
Related articles to: HSPB8 antibody
- In the diabetic heart, hyperglycemia can augment the covalent modification of Ca2+-calmodulin-dependent protein kinase II (CaMKII) by O-linked N-acetylglucosamine (O-GlcNAc). Concurrently, mitophagy serves as a crucial link in diabetic myocardial injury. The association between these two processes in diabetic cardiomyopathy remains to be elucidated. - Source: PubMed
Jiang YanjuanHu KaiboLuo ZhaoweiDuan HuiwenQi XinruiZheng XuehongZhang JingZou FangCai XiaNiu LiyanYu PengLai Xiaoyang - Acute ischemic stroke is a major cause of death and disability, yet many patients cannot engage in early rehabilitation due to severe motor deficits. Resulting immobility accelerates muscle atrophy and systemic inflammation, highlighting muscle-brain interactions as potential therapeutic targets. Electrical muscle stimulation (EMS) provides a non-volitional means of activating skeletal muscle and may mimic key neuroprotective features of exercise. We tested whether hyperacute EMS modulates muscle-to-brain signaling to improve stroke outcomes. Transient middle cerebral artery occlusion was induced in male and female C57BL/6 mice, followed by daily neurological assessments and 4 Hz lower-limb EMS for three days. Myofiber morphology, infarct size, blood lactate, and muscle and brain gene expression were subsequently analyzed. EMS preserved myofiber size and reduced stress-response gene expression (Hsp25, Hspb8, Atf4) in skeletal muscle. In the brain, EMS decreased infarct volume, limited necrosis, and improved neurological function. Stroke-associated inflammation was attenuated, evidenced by reduced Tnf, Nlrp3 and Aif1 expression. EMS elevated circulating lactate, while stroke groups showed increased expression of the monocarboxylate transporter Mct-1, supporting a lactate-dependent metabolic coupling mechanism. These findings identify hyperacute EMS as a feasible, noninvasive intervention that confers neuroprotective and anti-inflammatory benefits after stroke, potentially via lactate-mediated muscle-to-brain signaling. EMS may represent a valuable adjunct for patients unable to mobilize during the critical early phase of stroke recovery. - Source: PubMed
Publication date: 2026/06/02
Törteli AnnaKozák PéterUno HiroyukiHősi RajmundRuppert ZsófiaGáspár EszterBari FerencTörök ZsoltFarkas EszterTóth Melinda EMenyhárt Ákos - This study aims to investigate the role of the lncRNA LUCAT1 in cerebral infarction-induced neurological damage. In vitro experiments employed N2a cells to establish an OGD/R model, while in vivo experiments utilized male C57BL/6 mice to construct a MCAO model. Cell viability and apoptosis were assessed via the CCK-8 assay and flow cytometry, respectively. RT-qPCR measured mRNA expression of LUCAT1, miR-337-3p, and HSPB8. The molecular targeting relationship was validated using dual luciferase reporter assays and RNA pull-down experiments. ELISA was used to measure the levels of IL-6, IL-1β, and TNF-α. DCFH-DA fluorescent probes and commercial kits were employed to measure ROS levels, MDA and SOD activity. Neurological function assessment included Longa score, Bederson score, adhesive removal test, and modified neurological severity score. In both OGD/R and MCAO models, LUCAT1 expression was downregulated while miR-337-3p expression was upregulated. LUCAT1 was found to directly bind to miR-337-3p. Under OGD/R conditions, LUCAT1 overexpression enhanced cell viability, inhibited apoptosis, and alleviated inflammation and oxidative stress, with these protective effects being reversed by miR-337-3p overexpression. Animal experiments further confirmed that LUCAT1 overexpression improved neuroinflammation, oxidative stress, and neurological deficits in MCAO mice, an effect that was attenuated by co-expression of miR-337-3p. HSPB8 was identified as a direct target gene of miR-337-3p; inhibition of miR-337-3p exerted protective effects by upregulating HSPB8, whereas HSPB8 knockdown counteracted this protective effect. The long noncoding RNA LUCAT1 exerts neuroprotective effects in cerebral infarction by sponging miR-337-3p and relieving its inhibitory action on HSPB8. - Source: PubMed
Publication date: 2026/05/20
Lei LeiGuo MengnanZou Qixin - HSPB8 belongs to the small heat shock protein family, which comprises ten chaperones with molecular weights below 29 kDa. HSPB8 is broadly expressed across human tissues, with the highest levels in skeletal muscles, the cardiac muscle, and the nervous system. In muscles, HSPB8 plays a crucial role in chaperone-assisted selective autophagy (CASA), contributing to protein quality control and maintaining proteostasis. The most extensively studied mutations affecting the HSPB8 K141 codon are associated with autosomal dominant neuromuscular disorders such as Charcot-Marie-Tooth disease type 2L and distal hereditary motor neuropathy type 2 (dHMN2). Of note, recent findings have identified Myofibrillar Myopathy type 13 (MFM13) with Rimmed Vacuoles as a distinct disorder caused by frameshift (fs) mutations in the carboxy-terminus of HSPB8. This review focuses on the known HSPB8-fs mutations leading to MFM13, their associated clinical phenotypes and histological findings, and highlights the need to further understand the underlying etiologies and mechanisms. - Source: PubMed
Publication date: 2026/04/06
Zhou WenliMarchesi VeronicaMcLeod MatthewKordala Anna JolantaSzwec SylwiaMielcarz Julia AnnaPoletti AngeloTedesco Barbara - Filamin C is an adapter protein involved in the regulation of cytoskeleton; it interacts with more than 90 protein partners, including small heat shock proteins (sHsps). However, the details of filamin C interaction with sHsps remain poorly characterized. Here, we used immunochemistry methods, size-exclusion chromatography, native gel electrophoresis, and chemical crosslinking to investigate the interactions of a long C-terminal fragment of filamin C containing immunoglobulin (Ig)-like domains 19-24 (FLNC19-24) with sHsps. Out of five analyzed sHsps (HspB1, phosphorylation-mimicking 3D mutant of HspB1, HspB5, HspB6, HspB7, and HspB8), only HspB7 formed complexes with FLNC19-24. Taking into account that HspB7 interacted with the isolated Ig-like domain 24 and filamin fragments containing Ig-like domains 22-24 and 19-24, we concluded that HspB7 is a bona fide partner of filamin C. Selective binding of the α-crystallin domain of HspB7 with the Ig-like domain 24 induced dissociation of filamin dimers, which might promote filamin C translocation in the cell and facilitate the repairs of damaged contractile apparatus. - Source: PubMed
Zamotina Maria AMuranova Lidia KTyurin-Kuzmin Pyotr ASluchanko Nikolai NGusev Nikolai B